Stock Information
ACADIA Pharmaceuticals Inc (ACAD)
Ticker Symbol: ACAD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,347.61 mil
Piotroski score: 4
PE Ratio: 11.323
EPS (TTM): 2.1884
Revenue (TTM): $6.34 M
Dividend Yield: N/A%
ROE: 35.65%
Latest News
-
Tracking Baker Brothers Portfolio: Q1 2026 Update
Tue, Jul 21, 2026 1:26 PM
-
BMO Capital Maintains Outperform on ACADIA Pharmaceuticals, Raises Price Target to $36
Tue, Jul 21, 2026 8:29 AM
-
Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
Tue, Jul 21, 2026 7:51 AM
-
Stifel Maintains Hold on ACADIA Pharmaceuticals, Raises Price Target to $25
Tue, Jul 21, 2026 7:04 AM
-
Acadia Pharma Secures FDA Fast Track Designation For Remlifanserin For Treatment Of Hallucinations And Delusions Associated With Alzheimer’s Disease Psychosis
Mon, Jul 20, 2026 9:07 AM
-
Stoke Therapeutics: Its Dravet Syndrome Lead Asset Enters The Last Stretch
Sun, Jul 19, 2026 2:15 AM
Key Financials
Financial data not available
